Exelixis, Inc. v. Handa Pharmaceuticals, Inc.
Big pharmas routine patent fight is never routine. Its a strategy memo in disguise.
Thats the takeaway from Exelixis, Inc. v. Handa Pharmaceuticals, Inc.a case that may look narrow on the surface (a specific patent, a specific counterparty), but that…
